Sanofi - ADR (SNY) Social Stream



Sanofi - ADR (SNY): $48.88

0.40 (+0.83%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Sanofi (SNY) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering SNY.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
20 $69.86 $50.47 $60.82 $48.22 26.13%

The Trend in the Analyst Price Target


Over the past 85 days, SNY's average price target has gone down $0.82.

SNY reports an average of 23.59% for its upside potential over the past 164 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-11-20 20 69.86 50.47 60.82 50.52 20.39%
2020-11-19 20 69.86 50.47 60.82 50.88 19.54%
2020-11-10 20 68.20 50.47 60.71 50.17 21.01%
2020-10-31 20 68.20 49.54 60.54 45.30 33.64%
2020-09-30 20 68.99 50.27 61.46 50.17 22.5%
2020-09-22 19 68.99 50.27 62.06 49.86 24.47%
2020-09-16 19 68.99 50.27 62.14 NA NA%
2020-09-05 19 68.09 50.27 61.71 NA NA%
2020-08-27 19 68.09 50.27 61.64 NA NA%
2020-08-20 19 68.09 50.27 61.66 NA NA%
2020-08-12 19 65.51 50.26 61.01 NA NA%
2020-08-07 19 65.35 50.26 61.00 NA NA%
2020-07-23 19 64.51 48.32 59.53 NA NA%
2020-07-16 19 64.51 48.32 59.21 NA NA%
2020-07-08 19 64.02 47.73 58.80 NA NA%
2020-07-01 19 64.02 47.73 58.83 NA NA%
2020-06-25 19 64.12 48.17 58.29 NA NA%
2020-06-18 20 63.54 47.68 57.85 NA NA%
2020-06-11 20 63.00 48.25 57.81 NA NA%
2020-06-09 20 62.22 47.33 57.42 NA NA%

SNY Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs

The Trend in the Broker Recommendations


SNY's average broker recommendation rating worsened by 0.08 over the prior 61 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • The number of analysts covering the stock of SNY is greater than 93.35% of all US stocks.
  • Sanofi's upside potential (average analyst target price relative to current price) is higher than 15.8% of Pharmaceutical Products stocks.
  • SNY has a greater average analyst price target than 83.92% of Pharmaceutical Products stocks.
  • The variance in analysts' estimates of SNY is less than 63.17% of stocks in the large market cap category.

What is the outlook for SNY? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7426 seconds.